Notes et références
- 1 2 Les valeurs de la masse et du nombre de résidus indiquées ici sont celles du précurseur protéique issu de la traduction du gène, avant modifications post-traductionnelles, et peuvent différer significativement des valeurs correspondantes pour la protéine fonctionnelle.
- ↑ Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA, Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis, J Biol Chem, 2003;278:12029–12038
- ↑ Howden R, Nrf2 and cardiovascular defense, Oxid Med Cell Longev, 2013;2013:104308
- ↑ Itoh K, Wakabayashi N, Katoh Y et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev, 1999;13:76–86
- ↑ Joshi G, Johnson JA, The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases, Recent Pat CNS Drug Discov, 2012;7:218–229
- ↑ Mazzuferi M, Kumar G, van Eyll J, Danis B, Foerch P, Kaminski RM, Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy, Ann Neurol, 2013;74:560–568
- ↑ Tan SM, de Haan JB, Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?, Redox Rep, 2014;19:107–117
- ↑ Xiong W, MacColl Garfinkel1 AE, Li Y, Benowitz LI, Cepko CL, NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage, J Clin Invest, 2015;125:1433–1445
- ↑ Tom Clifford, Jarred P. Acton, Stuart P. Cocksedge et Kelly A. Bowden Davies, « The effect of dietary phytochemicals on nuclear factor erythroid 2-related factor 2 (Nrf2) activation: a systematic review of human intervention trials », Molecular Biology Reports, vol. 48, no 2, , p. 1745–1761 (ISSN 1573-4978, PMID 33515348, PMCID 7925463, DOI 10.1007/s11033-020-06041-x, lire en ligne, consulté le )
